METHYLPHENIDATE ER(LA) 30 MG CP

Methylphenidate Hydrochloride
$2.0778per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00093534701

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079031

On Market Since

7/16/2012

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-1.3%

3M

-10.8%

6M

-20.2%

1Y

-29.0%

3Y

-10.4%

5Y

+75.3%

All

-51.9%